Trial Profile
Effect of Cholesterol Lowering on the Progression of Aortic Stenosis in Patients With Mild to Moderate Aortic Stenosis (ASTRONOMER) Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin and The Sub-Study Protocol
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Feb 2020
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Aortic valve stenosis
- Focus Registrational; Therapeutic Use
- Acronyms ASTRONOMER
- Sponsors AstraZeneca
- 13 Feb 2020 Results assessing apolipoprotein CIII-lipoprotein(a) complexes (ApoCIII-Lp(a)) associate with progression of calcific aortic valve stenosis, published in the Heart.
- 07 Sep 2015 Results published in the Journal of the American College of Cardiology.
- 17 Jul 2012 Predefined substudy results published in the Journal of the American College of Cardiology.